SK Life Science will also host the "Prioritizing Seizure Treatments Through Real-World Patient Case Studies Symposium," an expert led panel to advance the discussion regarding the unmet need for ...
It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The unconventional approach of “The Shoe ...
SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer (DTC) ad, the Xcopri manufacturer asks ...
KING OF PRUSSIA, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, Co., Ltd., showcased its cutting-edge targeted ...
KING OF PRUSSIA, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, Co., Ltd., a global biotech focused on the research, development, and ...
KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of ...
SK Biopharmaceuticals will inject about 51.2 billion won into its U.S. subsidiary SK Life Science Labs, Inc. SK Biopharmaceuticals said on the 6th that its board approved taking part in a paid-in ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...
The positions in the table below reflect the SK Life Science Labs's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results